Literature DB >> 22633131

Totally implantable central venous access port infections in patients with digestive cancer: incidence and risk factors.

Abdoulaye Touré1, Philippe Vanhems, Catherine Lombard-Bohas, Philippe Cassier, Denis Péré-Vergé, Jean-Christophe Souquet, René Ecochard, Cécile Chambrier.   

Abstract

BACKGROUND: Central venous access port-related bloodstream infection (CVAP-BSI) is associated with morbidity and mortality in patients with cancer. This study examined the incidence rates and risk factors for CVAP-BSI in adult patients with digestive cancer.
METHODS: This prospective observational cohort study was performed from 2007 to 2011 in 2 oncology units of a university hospital. Incidence rate was expressed as number of CVAP-BSI per 1,000 catheter-days. A Cox regression model was used to identify risk factors for CVAP-BSI.
RESULTS: A total of 315 patients were included. CVAP-BSI occurred in 41 patients (13.0%). The overall incidence rate was 0.76/1,000 catheter-days. The rate was higher in patients with esophageal cancer (1.28. P = .05) and pancreatic cancer (1.24; P = .007). Risk factors independently associated with CVAP-BSI were World Health Organization performance status between 2 and 4, catheter utilization-days in the previous month, pancreatic cancer, and parenteral nutrition. Coagulase-negative Staphylococci and enterobacteria were the main microorganisms isolated.
CONCLUSIONS: In adult patients with digestive cancer, pancreatic cancer, cumulative catheter utilization-days, World Health Organization performance status, and parenteral nutrition were identified as independent risk factors for CVAP-BSI. Patients with any of these risk factors could be candidates for preventive strategies.
Copyright © 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22633131     DOI: 10.1016/j.ajic.2012.01.024

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  13 in total

1.  Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria.

Authors:  Maristela P Freire; Ligia C Pierrotti; Antonio E Zerati; Luciana Benites; Joaquim Mauricio da Motta-Leal Filho; Karim Y Ibrahim; Pedro H Araujo; Edson Abdala
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

2.  Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.

Authors:  R Berardi; S Rinaldi; D Santini; B Vincenzi; R Giampieri; E Maccaroni; F Marcucci; M Francoletti; A Onofri; A Lucarelli; C Pierantoni; G Tonini; S Cascinu
Journal:  Support Care Cancer       Date:  2014-10-19       Impact factor: 3.603

Review 3.  Therapeutic approach for digestive system cancers and potential implications of exercise under hypoxia condition: what little is known? a narrative review.

Authors:  Sergio Pérez Regalado; Josefa León; Belén Feriche
Journal:  J Cancer Res Clin Oncol       Date:  2022-02-14       Impact factor: 4.322

Review 4.  Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman.

Authors:  Philomena C D'Souza; Shiyam Kumar; Annupam Kakaria; Rashid Al-Sukaiti; Khalid Al-Baimani; Rana S Hamid; Alok K Mittal; Muna Al-Balushi; Ikram A Burney; Mansour S Al-Moundhri
Journal:  Sultan Qaboos Univ Med J       Date:  2021-03-15

Review 5.  Implantable Device-Related Infection.

Authors:  J Scott VanEpps; John G Younger
Journal:  Shock       Date:  2016-12       Impact factor: 3.454

6.  Catheter-Related Complications in Children With Cancer Receiving Parenteral Nutrition: Change in Risk Is Moderated by Catheter Type.

Authors:  Melissa A Shenep; Mary R Tanner; Yilun Sun; Tina Culley; Randall T Hayden; Patricia M Flynn; Li Tang; Joshua Wolf
Journal:  JPEN J Parenter Enteral Nutr       Date:  2016-01-07       Impact factor: 4.016

7.  A Study of Use of "PORT" Catheter in Patients with Cancer: A Single-Center Experience.

Authors:  Irappa Madabhavi; Apurva Patel; Malay Sarkar; Asha Anand; Harsha Panchal; Sonia Parikh
Journal:  Clin Med Insights Oncol       Date:  2017-02-23

8.  Right or left? Side selection for a totally implantable vascular access device: a randomised observational study.

Authors:  Wen-Ying Lin; Chih-Peng Lin; Chih-Hung Hsu; Ying-Hui Lee; Yi-Ting Lin; Meng-Chi Hsu; Yu-Yun Shao
Journal:  Br J Cancer       Date:  2017-08-08       Impact factor: 7.640

9.  Impact of chest subcutaneous fat on the occurrence of central venous port-related infectious complications in cancer patients.

Authors:  Jumpei Shibata; Hidetaka Kawamura; Kazuhiro Hiramatsu; Michitaka Honda; Yoshihisa Shibata; Taro Aoba; Masahiro Fujii; Atsuki Arimoto; Akira Ito; Kenta Ishii; Kojiro Omiya; Mariko Asai; Takuya Arakawa; Hirotake Gonda; Shuhei Asai; Takuya Hasegawa; Kento Kawashima; Takehito Kato
Journal:  Support Care Cancer       Date:  2021-03-10       Impact factor: 3.603

10.  A case-control study to identify risk factors for totally implantable central venous port-related bloodstream infection.

Authors:  Guk Jin Lee; Sook Hee Hong; Sang Young Roh; Sa Rah Park; Myung Ah Lee; Hoo Geun Chun; Young Seon Hong; Jin Hyoung Kang; Sang Il Kim; Youn Jeong Kim; Ho Jong Chun; Jung Suk Oh
Journal:  Cancer Res Treat       Date:  2014-07-15       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.